New study aims to spot eye damage early in rare vasculitis patients
NCT ID NCT07664709
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how ANCA-associated vasculitis affects the eyes. Researchers will use a special imaging test called OCT angiography to examine blood vessels in the eyes of 70 participants. The goal is to better understand and detect eye involvement early, which could help prevent vision loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve early detection of eye problems in people with ANCA vasculitis, potentially preventing vision loss.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve outcomes, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHURG-STRAUSS SYNDROME (CSS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Military Institute of Medicine National Research Institute
RECRUITINGWarsaw, 04-141, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could an arthritis drug shrink dangerous brain aneurysms?
- Massive study reveals hidden dangers of common steroid treatments
- 10-Year vasculitis study aims to predict relapses and improve care
- Small study tests rituximab against rare vessel disease
- Scientists track prednisolone levels to improve dosing for inflammatory conditions
- Blood samples could unlock secrets of autoimmune diseases